Home

ヘビー 検閲 シーズン kawasaki disease recurrence rate 挨拶 フライカイト 行動

The up‐to‐date pathophysiology of Kawasaki disease - Hara - 2021 - Clinical  & Translational Immunology - Wiley Online Library
The up‐to‐date pathophysiology of Kawasaki disease - Hara - 2021 - Clinical & Translational Immunology - Wiley Online Library

PDF) Recurrent lip swelling as a late presentation of Kawasaki disease:  Case report and review of literature
PDF) Recurrent lip swelling as a late presentation of Kawasaki disease: Case report and review of literature

Frontiers | Thirty Years of Kawasaki Disease: A Single-Center Study at the  University Hospital of Lausanne | Pediatrics
Frontiers | Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne | Pediatrics

Kawasaki disease in children: Epidemiology, clinical symptoms and  diagnostics of 231 cases in 10 years
Kawasaki disease in children: Epidemiology, clinical symptoms and diagnostics of 231 cases in 10 years

Recurrent Kawasaki disease and cardiac complications: nationwide surveys in  Japan | Archives of Disease in Childhood
Recurrent Kawasaki disease and cardiac complications: nationwide surveys in Japan | Archives of Disease in Childhood

Effective infliximab therapy for the early regression of coronary artery  aneurysm in Kawasaki disease - International Journal of Cardiology
Effective infliximab therapy for the early regression of coronary artery aneurysm in Kawasaki disease - International Journal of Cardiology

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A  Scientific Statement for Health Professionals From the American Heart  Association | Circulation
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation

The epidemiology of Kawasaki disease: a global update | Archives of Disease  in Childhood
The epidemiology of Kawasaki disease: a global update | Archives of Disease in Childhood

Kawasaki Disease | American Academy of Pediatrics
Kawasaki Disease | American Academy of Pediatrics

Frontiers | Antibodies and Immunity During Kawasaki Disease |  Cardiovascular Medicine
Frontiers | Antibodies and Immunity During Kawasaki Disease | Cardiovascular Medicine

Kawasaki disease: a matter of innate immunity - Hara - 2016 - Clinical  & Experimental Immunology - Wiley Online Library
Kawasaki disease: a matter of innate immunity - Hara - 2016 - Clinical & Experimental Immunology - Wiley Online Library

A 10-year cross-sectional retrospective study on Kawasaki disease in  Iranian children: incidence, clinical manifestations, complications, and  treatment patterns | BMC Infectious Diseases | Full Text
A 10-year cross-sectional retrospective study on Kawasaki disease in Iranian children: incidence, clinical manifestations, complications, and treatment patterns | BMC Infectious Diseases | Full Text

Recurrent Kawasaki disease and cardiac complications: nationwide surveys in  Japan
Recurrent Kawasaki disease and cardiac complications: nationwide surveys in Japan

Frontiers | Increased Incidence of Kawasaki Disease in Taiwan in Recent  Years: A 15 Years Nationwide Population-Based Cohort Study | Pediatrics
Frontiers | Increased Incidence of Kawasaki Disease in Taiwan in Recent Years: A 15 Years Nationwide Population-Based Cohort Study | Pediatrics

Recurrence of Kawasaki Disease in a Young Child
Recurrence of Kawasaki Disease in a Young Child

Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki  Disease: The Nationwide Survey in Japan, 2017-2018 - The Journal of  Pediatrics
Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018 - The Journal of Pediatrics

Clinical Practice Guidelines : Kawasaki disease
Clinical Practice Guidelines : Kawasaki disease

Abstract 134: Early Immunoglogulin Therapy and Outcomes of Kawasaki Disease  | Circulation
Abstract 134: Early Immunoglogulin Therapy and Outcomes of Kawasaki Disease | Circulation

Kawasaki's Disease
Kawasaki's Disease

Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse  Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study |  Journal of the American Heart Association
Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study | Journal of the American Heart Association

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease |  Circulation
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease | Circulation

Recurrent Kawasaki disease and cardiac complications: nationwide surveys in  Japan
Recurrent Kawasaki disease and cardiac complications: nationwide surveys in Japan

Refractory Kawasaki disease: diagnostic and management challenges | PHMT
Refractory Kawasaki disease: diagnostic and management challenges | PHMT

Searching for the cause of Kawasaki disease — cytoplasmic inclusion bodies  provide new insight | Nature Reviews Microbiology
Searching for the cause of Kawasaki disease — cytoplasmic inclusion bodies provide new insight | Nature Reviews Microbiology

Kawasaki disease recurrence in the COVID-19 era: a systematic review of the  literature | Italian Journal of Pediatrics | Full Text
Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature | Italian Journal of Pediatrics | Full Text